PIR and neoplasm: Nine pairs of clinical tissue samples (tumor and matched normal samples from the same patient) of luminal breast cancer were applied for piR-823 analysis, further indicating the upregulation of piR-823 in the tumors compared to normal tissues (Figure 1D).